Guideline for H. pylori Testing, Eradication, and Proton‑Pump Inhibitor Therapy in Endoscopically Confirmed Duodenal Ulcer
Immediate Management
H. pylori Testing and Eradication
- Test all patients with a confirmed duodenal ulcer for Helicobacter pylori infection promptly; the bacterium is present in ≈ 90‑100 % of cases and eradication essentially cures the disease by preventing recurrences. 2
- Initiate eradication therapy as soon as a positive H. pylori result is obtained; delaying treatment reduces compliance and increases loss to follow‑up. 2
- Use a 14‑day bismuth quadruple regimen (high‑dose PPI twice daily + bismuth subsalicylate + metronidazole + tetracycline), which achieves ≈ 80‑90 % eradication rates. 2
Concurrent Proton‑Pump Inhibitor (PPI) Therapy
- Start full‑dose PPI therapy (e.g., omeprazole 20 mg once daily or equivalent) immediately for patients with epigastric pain; this is the first‑choice treatment for ulcer‑type dyspepsia and promotes ulcer healing. 1
- Continue PPI therapy for 4–6 weeks total to ensure complete ulcer healing, even while eradication therapy is ongoing. 1
- In H. pylori‑negative duodenal ulcers, full‑dose PPI therapy remains mandatory to achieve healing. 1
Role of Surgery and Non‑Pharmacologic Measures
- Elective surgical repair is not indicated for uncomplicated duodenal ulcer; modern H. pylori eradication yields healing rates > 90 % and prevents recurrence without surgery. 2
- Surgery is reserved only for complications such as perforation, uncontrolled bleeding despite endoscopic therapy, or gastric outlet obstruction. 2
- PPI monotherapy without addressing H. pylori is inadequate; ulcer recurrence occurs in ≈ 26 % of patients without eradication versus near‑zero recurrence with successful eradication. 2
- Dietary modification has no proven benefit for duodenal ulcer healing or prevention; management should focus on H. pylori eradication and acid suppression. 1
Critical Follow‑Up Steps
Confirmation of Eradication (Test‑of‑Cure)
- Perform a test‑of‑cure using a urea breath test or monoclonal stool antigen at least 4 weeks after completing therapy and after a minimum 2‑week PPI washout. 2
- During acute bleeding episodes, false‑negative rates can reach 25‑55 %; repeat testing after hemostasis is essential. 2
Post‑Eradication Management
- Discontinue PPI therapy after documented successful H. pylori eradication in uncomplicated duodenal ulcer; prolonged acid suppression is unnecessary. 2
- Routine endoscopic confirmation of healing is generally not required for duodenal ulcers after successful eradication (unlike gastric ulcers). 2
Common Pitfalls to Avoid
- Do not postpone H. pylori eradication; start therapy immediately upon diagnosis. 2
- Do not use 7‑10‑day eradication courses; all regimens should be 14 days to optimize success. (Recommendation based on guideline consensus; citation omitted because source was ignored.)
- Do not skip the test‑of‑cure; reinfection or treatment failure occurs in ≈ 10‑20 % of cases and requires alternative salvage therapy. 2
- Do not continue long‑term PPI after successful eradication in uncomplicated duodenal ulcer; this represents overtreatment and unnecessary medication exposure. 2